Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use DEFLAZACORT TABLETS safely and effectively. See full prescribing information for DEFLAZACORT TABLETS DEFLAZACORT tablets, for oral use Initial U.S. Approval:2017
Medication labelWhy this: Advisory · dailymed-prescription
Deflazacort tablets are indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 2 years of age and older.
- generic_name
- deflazacort
- product_names
- Deflazacort
- ndc
- 81806-204, 81806-206, 81806-207, 81806-208, 81806-204-10, 81806-206-30, 81806-207-30, 81806-208-30
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en